Mark M. Pomerantz - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Xintao Qiu - Brandeis University, Rabb School of Continuing Studies, Division of Graduate Professional
Studies
Yanyun Zhu - Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands
David Y Takeda - The Eli and Edythe L. Broad Institute, Cambridge, MA, USA
Wenting Pan - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Sylvan C Baca - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Alexander Gusev - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Keegan D Korthauer - Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Tesa M Severson - Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Gavin Ha - Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Srinivas R Viswanathan - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Ji-Heui Seo - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Holly M Nguyen - Department of Urology, University of Washington, Seattle, WA, USA
Baohui Zhang - Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA
Bogdan Pasaniuc - Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Claudia Giambartolomei - Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
Sarah A Alaiwi - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Connor Bell - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Edward O'Connor - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Matthew S Chabot - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
David R Stillman - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Rosina Lis - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Alba Font-Tello - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Lewyn Li - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Paloma Cejas - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Andries M Bergman - Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Joyce Sanders - Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Henk G van der Poel - Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
Simon A Gayther - Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Kate Lawrenson - Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Marcos A S Fonseca - Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Jessica Reddy - Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Rosario I Corona - Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Gleb Martovetsky - Active Motif, Inc., Carlsbad, CA, USA
Brian Egan - Active Motif, Inc., Carlsbad, CA, USA
Toni Choueiri - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Leigh Ellis - Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA
Isla P Garraway - Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA
Gwo-Shu Mary Lee - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Eva Corey - Department of Urology, University of Washington, Seattle, WA, USA
Henry W. Long - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Wilbert Zwart - Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands. w.zwart@nki.nl
Matthew L. Freedman - The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. mfreedman@partners.org
